Consensus opinion on immune-mediated cytopenias after hematopoietic cell transplant for inherited metabolic disorders

Hematopoietic stem cell transplantation (HCT) has been increasingly used for patients with inherited metabolic disorders (IMD). Immune mediated cytopenias (IMCs) after HCT, manifesting as hemolytic anemia, thrombocytopenia, and/or neutropenia, are recognized as a significant complication in this pat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Bone Marrow Transplant
Main Authors: Gupta, Ashish O., Jan Boelens, Jaap, Ebens, Christen L., Kurtzberg, Joanne, Lund, Troy C., Smith, Angela R., Wagner, John E., Wynn, Robert, Blazar, Bruce R., Orchard, Paul J.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2021
Assuntos:
Perspective
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189901/
https://ncbi.nlm.nih.gov/pubmed/33441980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-01179-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares